{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:31:05Z","timestamp":1793932265824,"version":"4.8.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijantimicag.2026.108014","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:26:12Z","timestamp":1790097972000},"page":"108014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary penetration of intravenous rifabutin in healthy participants: A multiple-dose pharmacokinetic study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9196-1936","authenticated-orcid":false,"given":"Valentin","family":"al Jalali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm","family":"Jorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Pracher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Leutzendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Jackwerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7326-8310","authenticated-orcid":false,"given":"Marlene","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0982-6068","authenticated-orcid":false,"given":"Edith","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Supparitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Pecho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3682-2494","authenticated-orcid":false,"given":"Patrick","family":"Haselwanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Taschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2202-0689","authenticated-orcid":false,"given":"Maximilian","family":"Edlinger-Stanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4028-6432","authenticated-orcid":false,"given":"Lukas","family":"Infanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Marhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3591-9490","authenticated-orcid":false,"given":"Christina","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gompelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Idzko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Davila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Husband","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1012-5128","authenticated-orcid":false,"given":"Christian","family":"Kemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn E.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Zeitlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10325","key":"10.1016\/j.ijantimicag.2026.108014_bib0001","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"The Lancet"},{"issue":"14","key":"10.1016\/j.ijantimicag.2026.108014_bib0002","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa1914433","article-title":"Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017","volume":"382","author":"Jernigan","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ijantimicag.2026.108014_bib0003","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ijantimicag.2019.02.016","article-title":"Multidrug-resistant Acinetobacter baumannii infections: Current evidence on treatment options and the role of pharmacokinetics\/pharmacodynamics in dose optimisation","volume":"53","author":"Mohd Sazlly Lim","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.108014_bib0004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40560-015-0077-4","article-title":"Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"3","author":"Inchai","year":"2015","journal-title":"J Intensive Care"},{"issue":"9","key":"10.1016\/j.ijantimicag.2026.108014_bib0005","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41564-020-0737-6","article-title":"A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii","volume":"5","author":"Luna","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.108014_bib0006","unstructured":"Pfizer. Mycobutin 150 mg capsules. Pfizer Summary of Product characteristics. Revised 12\/2024."},{"issue":"11","key":"10.1016\/j.ijantimicag.2026.108014_bib0007","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3109\/00498259009046832","article-title":"Autoinduction of rifabutin metabolism in man","volume":"20","author":"Strolin Benedetti","year":"1990","journal-title":"Xenobiotica"},{"issue":"9","key":"10.1016\/j.ijantimicag.2026.108014_bib0008","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.drudis.2021.07.001","article-title":"Rifabutin for infusion (BV100) for the treatment of severe carbapenem-resistant Acinetobacter baumannii infections","volume":"26","author":"Trebosc","year":"2021","journal-title":"Drug Discov Today"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.108014_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01582-25","article-title":"Single-ascending and multiple-ascending dose study of the pharmacokinetics, safety, and tolerability of BV100 (rifabutin for infusion) in healthy volunteers","volume":"70","author":"Kemmer","year":"2026","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.ijantimicag.2026.108014_bib0010","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1093\/jac\/dkaa370","article-title":"In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms","volume":"75","author":"Trebosc","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.108014_bib0011","unstructured":"Muller AE, De Winter BCM, Gitzinger M, Kemmer C, Lociuro S, Pulse ME, et al. Pharmacokinetics and pharmacodynamics of BV100 in neutropenic mouse lung infection models. ECCMID 2021, online, 2021; Poster P3818."},{"issue":"11","key":"10.1016\/j.ijantimicag.2026.108014_bib0012","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/AAC.01533-06","article-title":"Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin","volume":"51","author":"Gumbo","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2026.108014_bib0013","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/clinids\/22.Supplement_1.S15","article-title":"The clinical pharmacokinetics of rifabutin","volume":"22","author":"Blaschke","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ijantimicag.2026.108014_bib0014","first-page":"743","article-title":"[A new anti-mycobacterial agent, rifabutin]","volume":"85","author":"Kurashima","year":"2010","journal-title":"Kekkaku"},{"key":"10.1016\/j.ijantimicag.2026.108014_bib0015","unstructured":"Pieren M, Muller AE, Pulse ME, Weiss WJ, De Jong WAM, Trebosc V, et al. Determination of the pharmacodynamic targets of BV100 in the neutropaenic murine thigh infection model. In: Poster of ESCMID Global 2025, Vienna, Austria, 2025; Poster P2490."},{"issue":"2","key":"10.1016\/j.ijantimicag.2026.108014_bib0016","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/11539220-000000000-00000","article-title":"The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients","volume":"50","author":"Ulldemolins","year":"2011","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"10.1016\/j.ijantimicag.2026.108014_bib0017","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/jac\/dkx541","article-title":"Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers","volume":"73","author":"Felton","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.ijantimicag.2026.108014_bib0018","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJMra070741","article-title":"Acinetobacter infection","volume":"358","author":"Munoz-Price","year":"2008","journal-title":"N Engl J Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926003018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926003018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:02:09Z","timestamp":1793930529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926003018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0924857926003018"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.108014","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary penetration of intravenous rifabutin in healthy participants: A multiple-dose pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.108014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108014"}}